Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 23,872 |
| Marketable Securities | 0 | 0 | 0 | 2,753 |
| Other current assets | 0 | 0 | 0 | 1,117 |
| TOTAL | $0 | $0 | $0 | $27,742 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 13,808 |
| Other Non-Current Assets | 0 | 0 | 0 | 684 |
| TOTAL | $N/A | $N/A | $N/A | $14,492 |
| Total Assets | $0 | $0 | $0 | $38,001 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 600 |
| Accrued Expenses | 0 | 0 | 0 | 1,959 |
| Other current liabilities | 0 | 0 | 0 | 1,561 |
| TOTAL | $0 | $0 | $0 | $4,120 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 53 |
| TOTAL | $N/A | $N/A | $N/A | $4,578 |
| Total Liabilities | $0 | $0 | $0 | $8,698 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -44,417 |
| Other shareholders' equity | 0 | 0 | 0 | 72,956 |
| TOTAL | $0 | $0 | $0 | $29,303 |
| Total Liabilities And Equity | $0 | $0 | $0 | $38,001 |